sEH-IN-25
sEH-IN-25 is an orally active soluble epoxide hydrolase (epoxide hydrolase) inhibitor, with an IC50 of 0.5 nM against human sEH and an IC50 of 2 nM against rat sEH. sEH-IN-25 can be used in the research of cardiovascular diseases.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 1141896-04-9
- Formule: C19H22BrF3N6O2
- Masse moléculaire:503.32
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
In Vitro
sEH-IN-25 potently inhibits soluble epoxide hydrolase activity in human embryonic kidney cells overexpressing human sEH with an IC50 of 3 nM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Parmacokinetics
Chemical Information
-
CAS No. 1141896-04-9
-
Masse moléculaire 503.32
-
Formule C19H22BrF3N6O2
-
SMILES
O=C(C1CCN(CC1)C2=NC(NC)=NC(C)=N2)NCC3=CC=C(C=C3OC(F)(F)F)Br
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocole
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)